The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells
Open accessAbstract
Mice homozygous for the F759 mutation in the gp130 interleukin (IL)-6 receptor subunit have enhanced gp130-mediated signal transducer and activator of transcription (STAT)3 activation and spontaneously developed a lymphocyte-mediated rheumatoid arthritis-like joint disease. Here, we show that the development of the disease is dependent on both major histocompatibility complex (MHC) II–restricted CD4+ T cells and IL-6 family cytokines. In spite of the necessity for CD4+ T cells, the gp130 mutation was only required in nonhemtopoietic cells for the disease. The gp130 mutation resulted in enhanced production of IL-7. Conditional knockout of STAT3 in nonlymphoid cells showed that the enhancement of IL-7 production was dependent on STAT3 activation by IL-6 family cytokines. Homeostatic proliferation of CD4+ T cells was enhanced in gp130 mutant mice and acceleration of homeostatic proliferation enhanced the disease, whereas the inhibition of homeostatic proliferation suppressed the disease. Anti–IL-7 antibody treatment inhibited not only the enhanced homeostatic proliferation, but also the disease in gp130 mutant mice. Thus, our results show that autoimmune disease in gp130 mutant mice is caused by increased homeostatic proliferation of CD4+ T cells, which is due to elevated production of IL-7 by nonhematopoietic cells as a result of IL-6 family cytokine-gp130-STAT3 signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Further, they act on fibroblasts and endothelial cells to recruit T helper 17 (Th17) cells, leading to an RA-like joint disease (F759 arthritis) and experimental autoimmune encephalomyelitis (EAE) (54, 66, 99).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In fact, a mutated gp130-mediated excessive production of cytokines and chemokines in non-immune cells in F759 mice is necessary for CD4(+) T-cell proliferation, Th17 cell accumulation in the lesion and the arthritis development (66, 99).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although the development of F759 arthritis is dependent on Th17 cells, the F759 mutation is required in non-immune cells but not immune cells, clearly indicating that the interaction between non-immune cells and immune cells is crucial for arthritis development in F759 mice (66, 99).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [99]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although the development of F759 arthritis is dependent on Th17 cells, the F759 mutation is required in non-immune cells but not immune cells, clearly indicating that the interaction between non-immune cells and immune cells is crucial for arthritis development in F759 mice (66, 99).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,653 · cited 1×
“20052187 1459 Autoimmune diseases comprise a heterogeneous group of poorly understood disorders that are controlled by genetic and environmental factors (1, 2).”
BackgroundSakaguchi, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,315
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,507
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. M. (2003) · Science · doi:10.1126/science.1078231 · Cited by 2,000
Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements
Kontoyiannis, D. L., Pasparakis, M., Pizarro, T. T., Cominelli, F., & Kollias, G. A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80038-2 · Cited by 1,329
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.387 · Cited by 1,328 · cited 17×
“The relative amount of CFSEhigh (A), CFSEmiddle (B), and CFSElow (C) cells, with the value for CFSEhigh defi ned as 1, is shown with error bars indicating 1 SD. (D) Incidence of arthritis with a score >2.0 in N7Txed F759 plus saline (open circles, n = 14), N7Txed F759 plus i.p. injection of fi ller T cells (closed tri…”
BackgroundInfluentialSetoguchi, R., Hori, S., Takahashi, T., & Sakaguchi, S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041982 · Cited by 1,234
IL-7 is critical for homeostatic proliferation and survival of naïve T cells
Tan, J. T., Dudl, E. P., LeRoy, E., Murray, R. M., Sprent, J., Weinberg, K. I., & Surh, C. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161126098 · Cited by 966 · cited 4×
“In fact, CD4+ T cell HP is signifi cantly impaired in MHCII- or IL-7–defi cient mice (12, 13).”
BackgroundInfluentialIL-6 in autoimmune disease and chronic inflammatory proliferative disease
Ishihara, K., & Hirano, T. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00027-8 · Cited by 807
Self-citationInterleukin 6 and its receptor: ten years later
Hirano, T. (1998) · International Reviews of Immunology · doi:10.3109/08830189809042997 · Cited by 788
Self-citation
Flagged first, then by citations
Research works printed but not linked: 3
- 2004, J. Clin. Invest., 114, 582, 10.1172/JCI200421795 · DOI
- 2003, Nat. Immunol., 4, 891
- 2004, Blood., 104, 2794
Cited by
Sorted by citations
Items 101–176 of 176
Fasnacht, N., Greweling‐Pils, M. C., Bollati‐Fogolín, M., Schippers, A., & Müller, W. (2009) · European Journal of Immunology · doi:10.1002/eji.200838710 · Cited by 18
The Importance of IL-6 in the Development of LAT-Mediated Autoimmunity
O’Brien, S. A., Zhu, M., & Zhang, W. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403187 · Cited by 18
“In addition to its role in T cell differentiation, IL-6 is also important for both T cell survival and proliferation (6, 7, 13, 15).”
Backgroundvan Roon, J. A. G., van der Wurff‐Jacobs, K. M. G., Verstappen, S. M. M., Bijlsma, J. W. J., & Lafeber, F. P. J. G. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.081059 · Cited by 17
“The correlation of changes in IL7 levels with changes in disease parameters that were not found for TNFα and IL18 points towards unique aspects of IL7 in regulation of inflammation in RA. The recent finding that IL7 blockade inhibits experimental autoimmune arthritis indicates the important arthritogenic capacity of I…”
BackgroundZhuang, J., Wu, L., Qian, M., Cai, P., Liu, Q.-B., Zhao, G., Li, Z., & Wu, Z. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.169093 · Cited by 17
Marrella, V., Poliani, P. L., Sobacchi, C., Grassi, F., & VILLA, A. M. (2008) · Trends in Immunology · doi:10.1016/j.it.2007.12.001 · Cited by 17
Potential roles of non-lymphocytic cells in the pathogenesis of IgG4-related disease
Cai, S., Hu, Z., Chen, Y., Zhong, J., & Dong, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940581 · Cited by 16
Intrauterine hyperglycemia induces liver inflammation in mouse male offspring
Dong, X., Lin, D., Sheng, J., & Xie, Y. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107974 · Cited by 15
Pathak, K. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.893295 · Cited by 15
“Both, IL-7-increased thymic output and peripheral expansion of T cells have been shown to contribute to expansion and maintenance of the T-cell pool [27,28].”
BackgroundWincewicz, A., Koda, M., SULKOWSKA, M., Koda, M., Wincewicz, D., & Sulkowski, S. (2010) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-009-0099-7 · Cited by 15
Characterization of a novel and spontaneous mouse model of inflammatory arthritis
Adipue, I. A., Wilcox, J., King, C., Rice, C., Shaum, K. M., Suard, C. M., ten Brink, E., Miller, S. D., & Mcmahon, E. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3399 · Cited by 8
Interleukin-6 expands homeostatic space for peripheral T cells
Hong, C., Nam, A. S., Keller, H. R., Ligons, D. L., Park, J., Yoon, H., Park, J. J., Luckey, M. A., & Park, J.-H. (2013) · Cytokine · doi:10.1016/j.cyto.2013.08.001 · Cited by 14
“IL-6 can directly induce T cell proliferation under lymphopenic conditions [40], and can indirectly induce T cell expansion by triggering excess IL-7 production in nonhematopoietic cells [41].”
BackgroundTsuji, F., Yoshimi, M., Katsuta, O., Takai, M., Ishihara, K., & Aono, H. (2009) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-10-23 · Cited by 17
“We reported that autoimmune disease in gp130 mutant mice is caused by increased homeostatic proliferation of CD4+ T-cells, which is due to elevated production of IL-7 by non-hematopoietic cells as a result of IL-6 family cytokine-gp130-STAT3 signaling [14].”
BackgroundSelf-citationGateway reflex: neural activation-mediated immune cell gateways in the central nervous system
Kamimura, D., Ohki, T., Arima, Y., & Murakami, M. (2018) · International Immunology · doi:10.1093/intimm/dxy034 · Cited by 12
Self-citationMalemud, C. J. (2010) · International Journal of Interferon Cytokine and Mediator Research · doi:10.2147/ijicmr.s9470 · Cited by 12
Gateway reflexes: A new paradigm of neuroimmune interactions
Ohki, T., Kamimura, D., Arima, Y., & Murakami, M. (2017) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12378 · Cited by 10
“We analyzed the pathogenesis of F759 mice autoimmunity and found that rather than immune cells, IL6 signaling in non-immune cells, such as endothelial cells and fibroblasts, is critical for the chronic inflammation, although the disease itself is dependent on activated CD4+ T cells.(32,35) Furthermore, the co-activati…”
BackgroundSelf-citationLiu, Z., Gu, J., Qin, Z., Yang, C., Yu, S., Dai, X., & Wang, K. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.03.203 · Cited by 9
“It has been well recognized that IL-1 and/or IL-6 exert their effects through the activation of STAT1 and STAT3, respectively (29-31).”
BackgroundCD4+T-cell subsets in rheumatoid arthritis
Ponchel, F., Vital, E. M. J., Kingsbury, S. R., & El-Sherbiny, Y. M. (2012) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.11.69 · Cited by 10
Hong, T.-H., Hu, F., Kuo, S., Ko, W., Chow, L., Hsu, L.-M., Huang, S., Yu, S., & Chen, Y. (2014) · IJC Metabolic & Endocrine · doi:10.1016/j.ijcme.2014.11.001 · Cited by 9
“One of IL-7 expression inducers is IL-6 [15].”
BackgroundKamimura, D., Arima, Y., Tsuruoka, M., Jiang, J., Bando, H., Meng, J., Sabharwal, L., Štofková, A., Nishikawa, N., Higuchi, K., et al. (2015) · International Immunology · doi:10.1093/intimm/dxv059 · Cited by 9
Self-citationLive from the Liver: Hepatocyte IL-7
Durum, S. K., & Mazzucchelli, R. I. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.001 · Cited by 9
“IL-7 induction had been reported to be driven in vitro by IFN-g (Ariizumi et al., 1995; Oshima et al., 2004) and tumor necrosis factor (TNF-a) (Weitzmann et al., 2000) and in vivo by keratinocyte growth factor (KGF) (Min et al., 2002) or IL-6 (Sawa et al., 2006).”
BackgroundInfection and autoimmunity: Lessons of animal models
Pásztói, M., Misják, P., György, B., Aradi, B., Szabó, T., Szántó, B., Holub, M. C., Nagy, G., Falus, A., & Buzás, E. I. (2011) · European Journal of Microbiology and Immunology · doi:10.1556/eujmi.1.2011.3.3 · Cited by 8
“Adjuvant arthritis [6] gp130R homozygous mutant arthritis [74]”
IL-6 and Inflammatory Diseases
Kamimura, D., Arima, Y., Hirano, T., Ogura, H., & Murakami, M. (2013) · Springer eBooks · doi:10.1007/978-4-431-54442-5_2 · Cited by 9
Self-citationNaïve T Cell Homeostasis Regulated by Stress Responses and TCR Signaling
Kamimura, D., Atsumi, T., Štofková, A., Nishikawa, N., Ohki, T., Suzuki, H., Katsunuma, K., Jiang, J., Bando, H., Meng, J., et al. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00638 · Cited by 8
“Homeostatic proliferation sometimes plays a role in the activation of autoreactive T cells, causing several autoimmune diseases (6, 7).”
BackgroundSelf-citationIL-7 is a Key Driver Cytokine in Spondyloarthritis?
Gonçalves, R. S. G., & Duarte, Â. L. B. P. (2019) · Journal of Immunology Research · doi:10.1155/2019/7453236 · Cited by 8
“Several other roles in human and experimental arthritis have recently been defined [16, 17]: IL-7 stimulates the production of proinflammatory cytokines in experimental arthritis [18], influences ectopic lymphoid neogenesis [19], promotes osteoclastogenesis [20, 21], and abolishes the function of regulatory T cells (T…”
BackgrounddEREGulated pathways: unraveling the role of epiregulin in skin, kidney, and lung fibrosis
Ezaddoustdar, A., Kalina, D., Bielohuby, M., Boehm, M., & Wygrecka, M. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00813.2024 · Cited by 7
Computer model of IL-6-dependent rheumatoid arthritis in F759 mice
Yamamoto, R., Yamada, S., Atsumi, T., Murakami, K., Hashimoto, A., Naito, S., Tanaka, Y., Ohki, I., Shinohara, Y., Iwasaki, N., et al. (2023) · International Immunology · doi:10.1093/intimm/dxad016 · Cited by 6
Self-citationIshihara, K., & Igarashi, H. (2012) · InTech eBooks · doi:10.5772/29113 · Cited by 5
“Furthermore, bone marrow transplantation experiment revealed a unique feature of gp130F759 that nonhematopoietic cells with a point mutation Y759F in gp130 are sufficient to induce passive but arthritogenic activation of wild type CD4+T cells (Sawa et al., 2006).”
BackgroundSelf-citationWu, J., Gu, J. H., Zhou, S., Lu, H., Lu, Y., Lu, L., & Wang, X. (2018) · Journal of Immunology Research · doi:10.1155/2018/1605341 · Cited by 6
Gateway reflex: Local neuroimmune interactions that regulate blood vessels
Kamimura, D., Ohki, T., Arima, Y., Ota, M., & Murakami, M. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.09.011 · Cited by 6
Self-citationKong, Y., Fuchsberger, M., Plebanski, M., & Apostolopoulos, V. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw102 · Cited by 4
“IL-6 has been shown to trigger a strong T-cell response [30].”
Feghhi-Najafabadi, S., & Shafiee, F. (2022) · PubMed Central · doi:10.30498/ijb.2021.278685.3021 · Cited by 4
Inflammation-induced cell-secreted migrasome promotes IL-6 expression in the recipient cells.
Saito, S., Yoshikawa, K., Tanaka, M., Murakami, M., & Okochi, M. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.214793 · Cited by 3
Self-citationParticipación de los linfocitos T en el desarrollo y perpetuación de la artritis reumatoide
Pablos, J. L. (2011) · Reumatología Clínica · doi:10.1016/j.reuma.2010.12.010 · Cited by 3
Role of Th17 cells and innate immunnity for the induction of autoimmune arthritis
Hashimoto, M., & Mimori, T. (2012) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.35.463 · Cited by 3
Okamoto, K., & Takayanagi, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00016-2 · Cited by 3
Yoshida, K., Misumi, M., Yamaoka, M., Kyoizumi, S., Ohishi, W., Sugiyama, H., Hayashi, T., & Kusunoki, Y. (2023) · Radiation Research · doi:10.1667/rade-23-00065.1 · Cited by 3
“Homeostatic proliferation of naive T cells in response to IL7 is known to involve the frequent appearance of CXCR3 high naive T cells ( 12 ), which can be enhanced by IL6 signaling ( 16 ).”
BackgroundResultExperimental Models for Rheumatoid Arthritis
Holmdahl, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00029-2 · Cited by 3
Cheng, X., Cui, C., Shen, S., Li, Z., Zhao, Y., Li, C., Kermode, A. G., Zhong, X., & Qiu, W. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578422 · Cited by 2
Aboelenin, M. M., Hefnawy, M., Emran, T. B., Shafey, H. I., & Zoheir, K. M. A. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01941-5 · Cited by 2
“Studies have shown that the transcription factor STAT-3 plays a critical role in the development of Th17 cells (Mori et al. 2011; Murakami and Hirano 2011; Sawa et al. 2006; Shouda et al. 2001; Yang et al. 2007).”
Chen, J., Zhuang, L., Li, Y., Wu, K., Duan, Y., Feng, J., Sun, D., Qu, Z., & Shi, L. (2023) · Transplant Immunology · doi:10.1016/j.trim.2023.101805 · Cited by 2
Teoh, Y. B., Jiang, J., Yamasaki, T., Nagata, N., Sugawara, T., Hasebe, R., Ohta, H., Sasaki, N., Yokoyama, N., Nakamura, K., et al. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1192888 · Cited by 2
Self-citationTsurui, R., Yamada, H., Natori, T., Yoshimura, M., Akasaki, Y., Kawahara, S., Niiro, H., Kunisaki, Y., & Nakashima, Y. (2024) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2024.100258 · Cited by 2
“It is also worth noting that IL-7-induced proliferation of CD4 T cells induces arthritis in a murine model of RA [37].”
The Reverse-Direction Method Links Mass Experimental Data to Human Diseases
Ogura, H., Atsumi, T., Bando, H., Sabharwal, L., Yamada, M., Jiang, J.-J., Nakamura, A., Arima, Y., Kamimura, D., & Murakami, M. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0255-9 · Cited by 1
“These results suggest that non-immune cells actively control the status of immune cells including CD4 T cells and dysregulation of this control can cause autoimmune diseases (Sawa et al. 2006).”
BackgroundSelf-citationvan den Berg, W. B. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06551-1.00087-7 · Cited by 2
Kamimura, D., Arima, Y., Štofková, A., Nishikawa, N., Higuchi, K., Ohki, T., & Murakami, M. (2016) · InTech eBooks · doi:10.5772/62938 · Cited by 1
“Using these autoimmune‐prone F759 mice, we performed mechanistic analyses for the pathogenesis of their autoimmunity and found that IL‐6 signaling in nonimmune cells, such as vascular endothelial cells and fibroblasts, rather than immune cells, is important for the exaggerated inflammation [61, 62].”
MethodSelf-citationInflammation amplifier and gateway reflex: The regulation of inflammation by neuroimmune interaction
Nakagawa, I., & Murakami, M. (2017) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.40.160 · Cited by 2
Self-citationMolatlhegi, R. P., Ngcobo, S., Liebenberg, L. J. P., Ngcapu, S., Mabhula, A., Leslie, A. J., Mchunu, N. N., Zondi, M. M., Adamson, J., Govender, K., et al. (2021) · American Journal of Reproductive Immunology · doi:10.1111/aji.13411 · Cited by 2
Rutherford, C. L., Hayley, D., & Timothy, M. (2012) · InTech eBooks · doi:10.5772/36588 · Cited by 1
“Interestingly, it was also found that Tyr759Phe-mutated gp130 must be present in non-haematopoietic cells, and that in response to IL-6 stimulation nonhaematopoietic cells expressing Tyr759Phe-mutated gp130 show enhanced production of IL7, leading to the activation and proliferation of CD4+ T cells (Sawa et al., 2006).”
BackgroundThe expression of IL-7RA in Egyptian patients with multiple sclerosis
Elshafie, S. M., Rasol, H. A. A., Helmy, H., & Younan, S. (2015) · Comparative Clinical Pathology · doi:10.1007/s00580-015-2064-5 · Cited by 1
“…IL-7 in the brain may contribute to the local expansion of these T cells. sIL-7RA levels are genetically driven by the rs6897932 [C] MS risk SNP. Targeting the IL-7RA pathway might be a promising therapeutic intervention in MS and other in autoimmune diseases, for example, RA (Sawa et al. 2006).”
BackgroundNeural signaling in immunology: the gateway reflex
Hasebe, R., Tanaka, H., Yamasaki, T., Murakami, K., & Murakami, M. (2025) · International Immunology · doi:10.1093/intimm/dxaf009 · Cited by 1
Self-citationImmune cell gateways in the central nervous system regulated by regional neural stimulations
Kamimura, D., Štofková, A., Nishikawa, N., Atsumi, T., Arima, Y., & Murakami, M. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12198 · Cited by 1
“Genetic studies showed that the development of arthritis in F759 mice requires CD4 T cells, IL-6 and IL-17A.(43,44) Consistently, the injection of IL-17A and IL-6 into F759”
BackgroundSelf-citationThe study of B cells and antibodies in Japan: a historical perspective.
Kurosaki, T. (2010) · International Immunology · doi:10.1093/intimm/dxq008 · Cited by 1
Regulatory T cells in the control of T cell homeostasis
Kawahata, K., Kanzaki, T., Imamura, M., Akahira, L., Michishita, K., Dohi, M., & Yamamoto, K. (2010) · Inflammation and Regeneration · doi:10.2492/inflammregen.30.502 · Cited by 1
Kamimura, D., Arima, Y., Atsumi, T., Meng, J., Sabharwal, L., Bando, H., Ogura, H., Jiang, J., Huseby, E. S., & Murakami, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800763-1.00006-3 · Cited by 1
Self-citationThe gateway reflex: breaking through the blood barriers
Murakami, K., Tanaka, Y., & Murakami, M. (2021) · International Immunology · doi:10.1093/intimm/dxab064 · Cited by 3
Self-citationRole of SOCS proteins during mycobacterial infections
Carow, B. (2012) · Figshare · Cited by 1
The myokine interleukin-7 may influence differentiation and migration of cultured satellite cells
Lian, H. (2009) · NORA - Norwegian Open Research Archives · Cited by 1
Oh, S. A. (2010) · ScholarlyCommons (University of Pennsylvania)
The Role of STAT3 Activation in Glomerulonephritis
Tsuji, F., Katsuta, O., & Aono, H. (2011) · InTech eBooks · doi:10.5772/24665
“Development of a rheumatoid arthritis-like disease is entirely dependent on mature lymphocytes, but abnormally enhanced homeostatic proliferation of CD4 T cells is caused by augmented production of IL-7 by non-hematopoietic stromal cells through a STAT3-dependent process (Sawa et al., 2006).”
BackgroundParticipation of T Lymphocytes in the Development and Perpetuation of Rheumatoid Arthritis
Álvarez, J. L. P. (2011) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2010.12.007
Cytokine partnership to destruction
Bird, L. (2006) · Nature reviews. Immunology · doi:10.1038/nri1889
Role of IL-7 and TSLP in immunopathology of (rheumatoid) arthritis
Hartgring, S. A. Y. (2005) · Utrecht University Repository (Utrecht University)
Montag, D. T. (2006) · D-Scholarship@Pitt (University of Pittsburgh)
Release of Soluble Interleukin-7 α Receptor (CD127) from CD8+ T-Cells and Human Thymocytes
Vidales, S. (2016) · uO Research (University of Ottawa) · doi:10.20381/ruor-5792
“IL-7 signaling has a role in development of RA [48].”
BackgroundAnimal Models of Inflammatory Arthritis
van den Berg, W. B. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3285-4.10025-7
Slauenwhite, D. (2017) · DalSpace (Dalhousie University)
Experimental Models for Rheumatoid Arthritis
Holmdahl, R. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1738-9.00028-1
Role of IL-1 in erosive arthritis, lessons from animal models
van den Berg, W. B., Joosten, L. A. B., & van de Loo, F. A. J. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8238-4_4
Musella, A., Balletta, S., Russo, C., Mariani, F., Tartacca, A., Rosa, G. D., Vito, F. D., Palmerio, F., Fresegna, D., Bruno, A., et al. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106523 · Cited by 1
Okamoto, K., & Takayanagi, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00001-3
Simonetta, F. (2011) · theses.fr (ABES) · doi:10.70675/032c421dzd23ez4b4aza677z79cae2e44063
Fan, Z., Dong, Q., Ding, L., Zhang, L., Yun, X., & Guo, H. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05713-y
Tanaka, Y., Wang, Y., Tanaka, H., Hojyo, S., Kamiya, N., Murakami, K., & Murakami, M. (2026) · Discover Nano · doi:10.1186/s11671-026-04830-0
Self-citationProteomic analysis of migrasomes derived from IL-6 amplifier-induced human breast cancer cells
Putra, A. B. R. D., Saito, S., Iwasaki, Y., Tanaka, M., & Okochi, M. (2026) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2026.08.001
Perez‐Witzke, D., Tiede, C., Lou, M., Guillet, M., Parmar, R., Robinson, J. I., & Ponchel, F. (2026) · Molecular Immunology · doi:10.1016/j.molimm.2026.09.004
Saghafian‐Hedengren, S. (2009)
Metadata
- Authors
- Sawa, S.-I., Kamimura, D., Jin, G.-H., Morikawa, H., Kamon, H., Nishihara, M., Ishihara, K., Murakami, M., & Hirano, T.
- Affiliations
- 1Laboratory of Developmental Immunology, Graduate School of Frontier Bioscience and Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan
- RIKEN (JP)
- The University of Osaka (JP)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-05-22
- Volume
- 203
- Issue
- 6
- Pages
- 1459-1470
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2118324
- OpenAlex
- W2133947803
- Cited by
- 176
- References
- 49
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 4 · 2020: 3 · 2019: 7 · 2018: 7 · 2017: 8 · 2016: 6 · 2015: 16 · 2014: 8 · 2013: 9 · 2012: 19
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- autoimmune arthritis, gp130, IL-6 receptor, STAT3, IL-7, IL-6 family cytokines, MHC class II-restricted T cells, non-hematopoietic cells
- MeSH terms
- Animals, Arthritis, Autoimmune Diseases, Disease Models, Animal, Flow Cytometry, Homeostasis, Homozygote, Humans, Lymphocyte Activation, Mice, Inbred C57BL, Mutation, Thymectomy, CD4-Positive T-Lymphocytes, Interleukin-7, STAT3 Transcription Factor, Cytokine Receptor gp130, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
